Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
11. Januar 2024 08:30 ET
|
Mustang Bio, Inc.
WORCESTER, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical...
Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
11. Januar 2024 08:15 ET
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that...